Examination Report |
1 | TM-1 | 22 Mar 2014 |
10 | Certificate | 05 Jul 2018 |
11 | TM-R(RENEWAL OF TRADE MARK) | 16 Mar 2024 |
2 | Power of Attorney | 22 Mar 2014 |
3 | Reply to Exam Report (MIS-R) | 26 Oct 2015 |
4 | Authorization Letter | 20 Jul 2017 |
5 | Authorization Letter | 22 Nov 2017 |
6 | Affidavit | 26 Dec 2017 |
7 | Authorization Letter | 05 Feb 2018 |
7 | Order | 05 Feb 2018 |
8 | Authorization Letter | 05 Feb 2018 |
8 | Order | 05 Feb 2018 |
9 | Journal Copy | 09 Apr 2018 |
1 | Hearing Notice (Show Cause) | 4848693 | 2100714 | 19 Jun 2017 |
2 | Hearing Notice (Adjourned) | 5247441 | 2253243 | 18 Oct 2017 |
3 | Hearing Notice (Adjourned) | 5673192 | 2434408 | 08 Jan 2018 |
4 | Tribunal ABA Notice for : 2703781 | 5826333 | 2491964 | 05 Feb 2018 |
5 | O3 NOTICE | 16918518 | 6442588 | 22 Dec 2023 |
6 | RENEWAL INTIMATION LETTER | 17791193 | 21 Mar 2024 |
The application for Concimax was made on 22 March 2014.
The trademark applicant for Concimax is INTAS PHARMACEUTICALS.
Concimax is applied in class(es) 5.
Application for Concimax is on Registered stage.
Application Id allotted to Concimax is 2703781.
Trademark agent or attorney for the application is Y. J. Trivedi & Co.
Concimax filed with the Intellectual property office as a WORD.